{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:17:01Z","timestamp":1789579021793,"version":"build-2803163510"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","award":["SeqMDRTB_NET"],"award-info":[{"award-number":["SeqMDRTB_NET"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["EvoLung"],"award-info":[{"award-number":["EvoLung"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["DZIF"],"award-info":[{"award-number":["DZIF"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2167"],"award-info":[{"award-number":["EXC 2167"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,10,26]]},"abstract":"<jats:p>\n                    The transmission of drug-resistant tuberculosis (TB) is a major problem for global TB control. Using genome sequencing, we showed that 13% of the multidrug-resistant (MDR)\n                    <jats:named-content content-type=\"genus-species\">M. tuberculosis<\/jats:named-content>\n                    complex strains from Namibia are already pre-extensively drug resistant (pre-XDR), which is substantial in an African setting.\n                  <\/jats:p>","DOI":"10.1128\/spectrum.01586-22","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T09:00:48Z","timestamp":1664269248000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia"],"prefix":"10.1128","volume":"10","author":[{"given":"M.","family":"Claassens","sequence":"first","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Dreyer","sequence":"additional","affiliation":[{"name":"Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany"},{"name":"German Center for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Borstel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nepolo","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Mokomele","sequence":"additional","affiliation":[{"name":"Namibia Institute of Pathology Limited, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"van Rooyen","sequence":"additional","affiliation":[{"name":"Namibia Institute of Pathology Limited, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ruswa","sequence":"additional","affiliation":[{"name":"National Tuberculosis and Leprosy Programme, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"},{"name":"Department of Pulmonology and Allergology, Inselspital Bern, Bern University Hospital, University of Bern, Bern, Switzerland"},{"name":"Katutura State Hospital, Ministry of Health and Social Services, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-0684","authenticated-orcid":true,"given":"S.","family":"Niemann","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"},{"name":"Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany"},{"name":"German Center for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Borstel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis.","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. 2021. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis. World Health Organization, Geneva, Switzerland. https:\/\/www.who.int\/publications-detail-redirect\/meeting-report-of-the-who-expert-consultation-on-the-definition-of-extensively-drug-resistant-tuberculosis."},{"key":"e_1_3_3_3_2","volume-title":"Global tuberculosis report 2019.","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. 2019. Global tuberculosis report 2019. World Health Organization, Geneva, Switzerland. https:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"e_1_3_3_4_2","volume-title":"Global tuberculosis report 2020.","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. 2020. Global tuberculosis report 2020. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_5_2","volume-title":"Global tuberculosis report 2021.","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. 2021. Global tuberculosis report 2021. World Health Organization, Geneva, Switzerland. https:\/\/apps.who.int\/iris\/handle\/10665\/346387."},{"key":"e_1_3_3_6_2","volume-title":"Namibia tuberculosis disease prevalence survey\u2014report 2019.","author":"Ministry of Health and Social Services","year":"2019","unstructured":"Ministry of Health and Social Services. 2019. Namibia tuberculosis disease prevalence survey\u2014report 2019. National Tuberculosis and Leprosy Programme, Windhoek, Namibia."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.18.0526"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5812"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039855"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3195"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01599-17"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21378-x"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30031-8"},{"key":"e_1_3_3_14_2","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance.","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. 2021. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38200"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-134"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2603.190525"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2878"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0022-2016"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201909-1819LE"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00793-8"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30079-6"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01796-2020"},{"key":"e_1_3_3_24_2","volume-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment.","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. 2019. WHO consolidated guidelines on drug-resistant tuberculosis treatment. World Health Organization, Geneva, Switzerland. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539517\/."},{"key":"e_1_3_3_25_2","volume-title":"Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine).","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. 2021. Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine). World Health Organization, Geneva, Switzerland. https:\/\/apps.who.int\/iris\/handle\/10665\/339275."},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0377-2020"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007297"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00353-10"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01833-10"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2018-0166"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02383-2019"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00470-9"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","unstructured":"Sonnenkalb L Carter J Spitaleri A Iqbal Z Hunt M Malone K Utpatel C Cirillo DM Rodrigues C Nilgiriwala KS CRyPTIC Consortium Fowler PW Merker M Niemann S. 2021. Deciphering bedaquiline and clofazimine resistance in tuberculosis: an evolutionary medicine approach. bioRxiv. doi:10.1101\/2021.03.19.436148.","DOI":"10.1101\/2021.03.19.436148"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.2.406-409.1993"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msu300"},{"key":"e_1_3_3_38_2","unstructured":"Rambaut A. 2013. FigTree. http:\/\/tree.bio.ed.ac.uk\/software\/figtree\/."},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001387"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70277-3"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1038"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5268.1641"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab359"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01586-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01586-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T10:17:56Z","timestamp":1666779476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.01586-22"}},"subtitle":[],"editor":[{"given":"Luiz Pedro Sorio","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10,26]]}},"alternative-id":["10.1128\/spectrum.01586-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.01586-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"2022-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01586-22"}}